Iovance Biotherapeutics (IOVA) P/E US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -8.56 | -2.57 | -4.31 | -5.76 | -2.50 | -4.30 | ||
| Changes by years, y/y, % | -66% | -70% | +67% | +34% | -57% | -36.9% | |||
Iovance Biotherapeutics. P/E
Iovance Biotherapeutics. P/E, changes, %
Iovance Biotherapeutics (IOVA) P/E US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| P/E | ? | -6.06 | -2.86 | -1.48 | -1.99 | -2.84 | -4.30 | |
| Changes by years, y/y, % | +29% | -67% | -72% | -71% | -53% | |||
| Changes by quarters, q/q, % | -13% | -53% | -48% | +35% | +43% | |||